151 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
and the imputed financial charge related to contingent consideration) that are unusual, non-recurring in nature or unrelated to Takeda’s ongoing
6-K
TAK
Takeda Pharmaceutical Co
1 Feb 24
Current report (foreign)
6:06am
and the imputed financial charge related to contingent consideration) that are unusual, non-recurring in nature or unrelated to Takeda’s ongoing operations
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
1 Feb 24
Current report (foreign)
6:06am
in nature or unrelated to Takeda’s ongoing operations and the tax effect of each of the adjustments, divided by the average outstanding shares
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
members of the Directors and of the Company by proactively continuing to inquire the nature of, to encourage improvement in and to make suggestions
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
) that are unusual, non-recurring in nature or unrelated to Takeda’s ongoing operations and the tax effect of each of the adjustments, divided by the average
6-K
u2vwq e2y0x6
30 Oct 23
Current report (foreign)
6:02am
6-K
EX-99.1
pofywlajg3yc
26 Oct 23
Current report (foreign)
6:20am
6-K
haus27crz 12t
26 Oct 23
Current report (foreign)
6:20am
6-K
oecg28
1 Aug 23
Current report (foreign)
6:10am
6-K
qtb osn1bzx91
27 Jul 23
Current report (foreign)
6:05am
6-K
EX-99.1
1qn4oq
27 Jul 23
Current report (foreign)
6:05am
6-K
EX-99.1
494ywyw1b8akub
12 Jul 23
Current report (foreign)
6:07am
6-K
EX-99.1
jk59 w3cskcx1
6 Jul 23
Current report (foreign)
6:18am
S-8
EX-5.1
kppmbnsoyff1z j7
28 Jun 23
Registration of securities for employees
6:35am
6-K
EX-99.1
ii3670ijf
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
gbrcviz q1u97hs3ty7
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
1np4ugt
30 May 23
Current report (foreign)
6:11am